Skip to content
healthcare.dev

Guaifenesin Extended-Release 1200 mg

NDC 53041-234, Guaifenesin, tablet, extended release, from Guardian Drug Company.

Product NDC
53041-234
Status
Listed
Labeler
Guardian Drug Company
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53041-234 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1
Package NDCNDC-11Package
53041-234-37530410234374 BLISTER PACK in 1 CARTON (53041-234-37) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
53041-234-47530410234476 BLISTER PACK in 1 CARTON (53041-234-47) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
53041-234-58530410234582 BLISTER PACK in 1 CARTON (53041-234-58) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53041-234 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53041-234 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53041-234. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.